79 papers found
Refreshing results…
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
Autocrine CCL19 blocks dendritic cell migration toward weak gradients of CCL21
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccine
Randomized phase III study comparing non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor-infiltrating lymphocytes and interleukin-2 to standard ipilimumab treatment in metastatic melanoma.
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Immune Monitoring Using mRNA-Transfected Dendritic Cells
Large-Scale mRNA Transfection of Dendritic Cells by Electroporation in Continuous Flow Systems
Transfection of Tumor-Infiltrating T Cells with mRNA Encoding CXCR2
Broadening the repertoire of melanoma-associated T-cell epitopes
Tryptophan 2,3-dioxygenase (TDO)-reactive T cells differ in their functional characteristics in health and cancer
Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells
T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
Spontaneous presence of FOXO3-specific T cells in cancer patients
Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor
T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
Genetic engineering of T cells for increased homing to the tumor site
High frequency of T cells specific for cryptic epitopes in melanoma patients
Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells
HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
Missing publications? Read more about our data sources.